Bliss GVS Pharma informs about disclosure

07 Nov 2024 Evaluate

Pursuant to the provisions of Regulation 30 read with sub-para 20, Part A, Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, Bliss GVS Pharma has submitted the disclosure regarding Audit observation letter imposing GST liability with interest & penalty against the Company. The details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, are provided ‘Annexure-I’.

The above information is a part of company’s filings submitted to BSE.

Bliss GVS Pharma Share Price

160.80 -10.25 (-5.99%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×